20
Cayman Pharma Sro, based in Czech Republic, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Cayman Pharma is Europe's most reliable and versatile source for Prostaglandin APIs//FDA approved.
One of their notable products is TRAVOPROST, with a corresponding US DMF Number 22289.
Remarkably, this DMF maintains an Active status since its submission on December 08, 2008, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 27, 2013, and payment made on February 08, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II